Latest filing published 05 Oct 2026 for Emergent BioSolutions Inc., €17k.
This profile gathers the share dealings of Paul Anthony Williams in Emergent BioSolutions Inc., where the filings describe the role as senior executive. The record holds 20 filings, for trades running from 23 February 2023 to 1 October 2026.
Sales make up the whole of the open-market record (2 sales, €46k). Besides market trades, the filings include 17 share grants. In 2026 alone, the filings show no purchases and 2 sales.
Most recently, on 5 October 2026, the filings show an open-market sale worth €17k in Emergent BioSolutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations